Company: GSHRW
Filing Date: 2025-02-27
Form Type: S-1/A
Source: 0001213900-25-018139
Chunk: 312

Company: Gesher Acquisition Corp. II
Filing Date: 2025-02-27
Form: S-1/A
Chunk 312
---
writers for deferred underwriting commissions to be placed in a trust account located in the United States. The deferred commissions will be released to the underwriters only on completion of an initial business combination. The deferred underwriting commissions will be payable as follows: (i) $0.20 per unit sold in this offering will be paid to the underwriters in cash; (ii) up to $0.10 per unit sold in this offering will be paid to the underwriters in cash, based on the percentage of public shares outstanding immediately prior to the consummation of our initial business combination net of public shares submitted for redemption and net of any public shares held by public shareholders that have entered into forward purchase agreements or other arrangements whereby we have a contractual obligation to repurchase such shares after the closing of the initial business combination; and (iii) up to $0.05 per unit sold in this offering will be paid to the underwriters in cash, provided that we will have the right, in our sole discretion, to reallocate any portion of such amount for the payment of expenses in connection such initial business combination. If we do not complete our initial business combination within the time period required by its amended and restated memorandum and articles of association, the underwriters have agreed that (i) they will forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in the trust account, and (ii) that the deferred underwriters’ discounts and commissions will be distributed on a pro ratabasis, together with any interest earned on the funds held in the trust account and not previously released to the company to pay the company’s taxes, to the public shareholders. The non -managingsponsor investors have expressed to us an interest in purchasing up to an aggregate of approximately $36million of the public units in this offering at the offering price (assuming the exercise in full of the underwriters’ over -allotmentoption)., or up to 25% of this offering None of the non -managingsponsor investors has expressed to us an interest in purchasing more than 9.9% of the units to be sold in this offering. There can be no assurance that the non -managingsponsor investors will acquire any units, either directly or indirectly, in this offering, or as to the amount of the units these investors will retain, if any, prior to or upon the consummation of our initial business combination. Because these expressions of interest are not binding agreements or commitments to